ATE232557T1 - Mit chemotherapeutische zusammensetzungenassoziierten genetischen suppressor-elementen - Google Patents

Mit chemotherapeutische zusammensetzungenassoziierten genetischen suppressor-elementen

Info

Publication number
ATE232557T1
ATE232557T1 AT94912200T AT94912200T ATE232557T1 AT E232557 T1 ATE232557 T1 AT E232557T1 AT 94912200 T AT94912200 T AT 94912200T AT 94912200 T AT94912200 T AT 94912200T AT E232557 T1 ATE232557 T1 AT E232557T1
Authority
AT
Austria
Prior art keywords
elements associated
genetic suppressor
suppressor elements
chemotherapeutic compositions
elements
Prior art date
Application number
AT94912200T
Other languages
English (en)
Inventor
Igor B Roninson
Andrei Gudkov
Original Assignee
Univ Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Illinois filed Critical Univ Illinois
Application granted granted Critical
Publication of ATE232557T1 publication Critical patent/ATE232557T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1072Differential gene expression library synthesis, e.g. subtracted libraries, differential screening
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1079Screening libraries by altering the phenotype or phenotypic trait of the host
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1082Preparation or screening gene libraries by chromosomal integration of polynucleotide sequences, HR-, site-specific-recombination, transposons, viral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67General methods for enhancing the expression
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90Isomerases (5.)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/44Multiple drug resistance

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
AT94912200T 1993-03-09 1994-03-08 Mit chemotherapeutische zusammensetzungenassoziierten genetischen suppressor-elementen ATE232557T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3308693A 1993-03-09 1993-03-09
PCT/US1994/002519 WO1994020618A1 (en) 1993-03-09 1994-03-08 Genetic suppressor elements associated with sensitivity to chemotherapeutic drugs

Publications (1)

Publication Number Publication Date
ATE232557T1 true ATE232557T1 (de) 2003-02-15

Family

ID=21868485

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94912200T ATE232557T1 (de) 1993-03-09 1994-03-08 Mit chemotherapeutische zusammensetzungenassoziierten genetischen suppressor-elementen

Country Status (9)

Country Link
EP (1) EP0694068B1 (de)
JP (1) JPH08507919A (de)
KR (1) KR100267837B1 (de)
AT (1) ATE232557T1 (de)
CA (1) CA2157770A1 (de)
DE (1) DE69432120T2 (de)
NO (1) NO953560L (de)
WO (1) WO1994020618A1 (de)
ZA (1) ZA941637B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753432A (en) * 1990-10-19 1998-05-19 Board Of Trustees Of The University Of Illinois Genes and genetic elements associated with control of neoplastic transformation in mammalian cells
ZA9544B (en) * 1994-01-05 1996-02-13 Univ Illinois Association of kinesin with sensitivity to chemotherapeutic drugs
US6001632A (en) * 1996-05-15 1999-12-14 Incyte Pharmaceuticals, Inc. Human protein disulfide isomerase
US5798249A (en) * 1996-05-15 1998-08-25 Incyte Pharmaceuticals, Inc. Human protein disulfide isomerase
WO1999032618A1 (en) * 1997-12-19 1999-07-01 Strata Biosciences Incorporated Non-bacterial cloning in delivery and expression of nucleic acids
WO1999041371A1 (en) 1998-02-13 1999-08-19 Genetrace Systems, Inc. Use of ribozymes for functionating genes
CA2327830A1 (en) * 1998-04-09 1999-10-21 Iconix Pharmaceuticals Inc. Methods for identifying genetic determinants associated with modulation of test compound activity
EP1161528A1 (de) 1999-03-12 2001-12-12 GPC Biotech Inc. Methoden und reagentien zur identifikation von synthetischen genetischen elementen
CA2392959A1 (en) * 1999-12-02 2001-06-07 Signalgene Inc. Preparation of sequence libraries from non-denatured rna and kits therefor
US20010049104A1 (en) * 2000-03-24 2001-12-06 Stemmer Willem P.C. Methods for modulating cellular and organismal phenotypes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5217889A (en) * 1990-10-19 1993-06-08 Roninson Igor B Methods and applications for efficient genetic suppressor elements

Also Published As

Publication number Publication date
ZA941637B (en) 1995-02-22
EP0694068A1 (de) 1996-01-31
JPH08507919A (ja) 1996-08-27
EP0694068B1 (de) 2003-02-12
WO1994020618A1 (en) 1994-09-15
DE69432120D1 (de) 2003-03-20
CA2157770A1 (en) 1994-09-15
KR960701202A (ko) 1996-02-24
KR100267837B1 (ko) 2001-03-02
NO953560D0 (no) 1995-09-08
DE69432120T2 (de) 2003-12-11
NO953560L (no) 1995-11-02

Similar Documents

Publication Publication Date Title
AU543054B2 (en) Heterocyclic amine derivatives
NZ306653A (en) Isolated dna il-17 receptors
TR200001023T2 (tr) Alfa-aril-N-Alkilnitronlar ve onları içeren farmasötik kompozisyonlar.
DK458480A (da) Dna, recombinant plasmid og mikroorganisme indeholdende dette samt fremgangsmaader til fremstilling deraf
ATE233785T1 (de) Onkoprotein protein kinase
ATE232557T1 (de) Mit chemotherapeutische zusammensetzungenassoziierten genetischen suppressor-elementen
ES2171417T3 (es) Uso de aislados de bacillus thuringiensis para controlar plagas de la familia aphididae.
DE3884605D1 (de) Feuerbestaendige zusammensetzung.
WO1995022612A3 (en) Genes and genetic elements associated with sensitivity to platinum-based drugs
FR2710074B1 (fr) Gène GRB3-3, ses variants et leurs utilisations.
DE3876902D1 (de) Stromsensitiver differenzverstaerker.
DE68922931D1 (de) Gammastrahlenbeständige Polycarbonatzusammensetzungen.
NO960715L (no) Fremgangsmåter for sceening av anti-östrogen forbindelser
DE69005136D1 (de) Grundierungszusammensetzung.
IE810767L (en) Prepartion of 2, 2, 6, 6-tetramethylpiperidone-4.
DE69103629D1 (de) Pendelvektor für die entwicklung von einem rekombinanten bacillus thuringiensis-stamm.
NO985079L (no) Eksplosiv formulering
FI851511L (fi) Foerbaettrat foerfarande foer tvaettning av brun maeld.
NO880099D0 (no) Beskyttelseskrage for karbonanoder.
FI940822A0 (fi) Foerfarande foer mikrobiologisk rening av material, som innehaoller skadliga aemnen
Dell Social Influence: Theory or Metatheory?
IT1209278B (it) Polimero clorurato e composizione per rivestimento che impiega tale polimero.
IT8521822A0 (it) Composizioni polimeriche stabilizzate e stabilizzanti adatti allo scopo.
IT1213197B (it) Xantinilmetil-tiazolidine e composizioni farmaceutiche che le contengono.
HUP9700481A2 (hu) PHA 037 fajtanevű, beltenyésztett napraforgóvonal (Helianthus annuus L.)

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties